ORIGINAL ARTICLE

JOP. J Pancreas (Online) 2005; 6(2):143-151.

Pancreatectomy Using the No-Touch Isolation Technique Followed by Extensive Intraoperative Peritoneal Lavage to Prevent Cancer Cell Dissemination: A Pilot Study

Masahiko Hirota, Shinya Shimada, Kenichiro Yamamoto, Eiji Tanaka, Hiroki Sugita, Hiroshi Egami, Michio Ogawa

Department of Gastroenterological Surgery, Kumamoto University. Honjo, Kumamoto-city, Japan

ABSTRACT

Context In pancreatic cancer, even for patients who have undergone curative resection (R0), survival analysis has revealed a poor survival rate due to cancer recurrence. Because the operation itself might have caused the dissemination of these cancer cells, the no-touch isolation technique and extensive intraoperative peritoneal lavage may be a potential operative procedure for improving the outcome.

Patients Eight patients treated by the no-touch isolation technique were compared with 10 patients treated using conventional techniques.

Main outcome measures Cancer cell detection rates in the portal venous blood, frequency of recurrence, and survival rate. We also analyzed the lymphatic fluid squeezed from the resected cancerous pancreatic tissue.

Results In 5 out of 10 cases (50%) in the conventional procedure group, CEA mRNA was identified in the portal blood after tumor manipulation, while only 1 out of 8 cases (13%) in the no-touch isolation technique group was positive for portal CEA mRNA. All lymphatic fluid samples squeezed from the resected cancerous pancreatic tissue were positive (8/8) for CEA mRNA. The recurrence rate was 90% (9/10) in the conventional procedure group, and 38% (3/8) in the no-touch isolation technique group (P=0.043). In the conventional procedure group, hepatic metastasis, local recurrence, peritoneal dissemination, and extraabdominal recurrence were identified in 6 (60%), 4 (40%), 4 (40%), and 2 patients (20%), respectively. On the other hand, among the no-touch isolation technique group, recurrence was identified in 1 (13%), 1 (13%), 0 (0%), and 1 patient (13%), respectively. There was no peritoneal dissemination along with the decreased hepatic recurrence rate. Mean (±SEM) survival time was 21.2±5.8 months for the conventional procedure group and 41.5±5.6 months for the no-touch isolation technique group (P=0.018). The 3-year survival rate was 12.5±11.5% for the conventional procedure group and 75.0±21.7% for the no-touch isolation technique group.

Conclusion This study presented the potential of cancer dissemination during the intraoperative manipulation of tumors and its contribution to cancer recurrence, as well as the significance of the no-touch isolation technique and extensive intraoperative peritoneal lavage for pancreatic cancer surgery.

Full text: HTML format  PDF format
  Look up who cited this article

References

  1. Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 2003; 27:324-9. [More details]

  2. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 1997; 21:195-200. [More details]

  3. Takahashi S, Ogata Y, Miyazaki H, Maeda D, Murai S, Yamataka K, Tsuzuki T. Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations. World J Surg 1995; 19:653-9. [More details]

  4. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Ann Surg 1995; 221:59-66. [More details]

  5. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993; 72:2118-23. [More details]

  6. Hosch SB, Knoefel WT, Metz S, Stoecklein N, Niendorf A, Broelsch CE, Izbicki JR. Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas 1997; 15:154-9. [More details]

  7. Tamagawa E, Ueda M, Takahashi S, Sugano K, Uematsu S, Mukai M, et al. Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma. Clin Cancer Res 1997; 3:2143-9. [More details]

  8. Demeure MJ, Doffek KM, Komorowski RA, Redlich PN, Zhu YR, Erickson BA, et al. Molecular metastases in stage I pancreatic cancer: improved survival with adjuvant chemoradiation. Surgery 1998; 124:663-9. [More details]

  9. Thorban S, Roder JD, Siewert JR. Immunocytochemical detection of isolated epithelial tumor cells in bone marrow of patients with pancreatic carcinoma. Am J Surg 1996; 172:297-8. [More details]

  10. Fernandez-del Castillo C, Rattner DW, Warshaw AL. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic carcinoma. Br J Surg 1995; 82:1127-9. [More details]

  11. Barnes JP. Physiologic resection of the right colon. Surg Gynecol Obstet 1952; 94:722-6. [More details]

  12. Turnbull RB Jr, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967; 166:420-7. [More details]

  13. Hirota M, Ogawa M. Pancreatoduodenectomy using no-touch isolation technique. Shujutsu 2001; 55:209-15. (In Japanese) [More details]

  14. Kobayashi S, Asano T, Ochiai T. A proposal of no-touch isolation technique in pancreatoduodenectomy for periampullary carcinomas. Hepatogastroenterology 2001; 48:372-4. [More details]

  15. Shimada S, Tanaka E, Marutsuka T, Honmyo U, Tokunaga H, Yagi Y, et al. Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells. Gastric Cancer 2002; 5:168-72. [More details]

  16. Nakao A, Takagi H. Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein. Hepatogastroenterology 1993; 40:426-9. [More details]

  17. Nomoto S, Nakao A, Kasai Y, Harada A, Nonami T, Takagi H. Detection of ras gene mutation in peri-operative peripheral blood with pancreatic adenocarcinoma. Jpn J Cancer Res 1996; 87:793-7. [More details]

  18. Funaki NO, Tanaka J, Hosotani R, Kogire M, Suwa H, Imamura M. Quantitative analysis of carcinoembryonic antigen messenger RNA in peripheral venous blood and portal blood of patients with pancreatic ductal adenocarcinoma. Clin Cancer Res 1998; 4:855-60. [More details]

  19. Takao S, Aikou T, Shinchi H, Uchikura K, Kubo M, Imamura H, Maenohara S. Comparison of relapse and long-term survival between pylorus-preserving and Whipple pancreaticoduodenectomy in periampullary cancer. Am J Surg 1998; 176:467-70. [More details]

  20. Hayashi N, Egami H, Kai M, Kurusu Y, Takano S, Ogawa M. No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer. Surgery 1999; 125:369-74. [More details]

  21. Suwa H, Hosotani R, Kogire M, Doi R, Ohshio G, Fukumoto M, Imamura M. Detection of extrapancreatic nerve plexus invasion of pancreatic adenocarcinoma. Cytokeratin 19 staining and K-ras mutation. Int J Pancreatol 1999; 26:155-62. [More details]

  22. Takahashi T, Ishikura H, Motohara T, Okushiba S, Dohke M, Katoh H. Perineural invasion by ductal adenocarcinoma of the pancreas. J Surg Oncol 1997; 65:164-70. [More details]

  23. Nagakawa T, Mori K, Nakano T, Kadoya M, Kobayashi H, Akiyama T, et al. Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg 1993; 80:619-21. [More details]

  24. Hirota M, Egami H, Corra S, Fujii H, Chaney WG, Rizzino A, Pour PM. Production of scatter factor-like activity by a nitrosamine-induced pancreatic cancer cell line. Carcinogenesis 1993; 14:259-64. [More details]

  25. Kurizaki T, Egami H, Hirota M, Akagi J, Ohmachi H, Yamamoto S, Ogawa M. Characterization of cancer cell dissociation factor in a highly invasive pancreatic cancer cell line. Cancer 1995; 75(6 Suppl):1554-61. [More details]

  26. Nozawa F, Hirota M, Okabe A, Shibata M, Iwamura T, Haga Y, Ogawa M. Tumor necrosis factor alpha acts on cultured human vascular endothelial cells to increase the adhesion of pancreatic cancer cells. Pancreas 2000; 21:392-8. [More details]

  27. Marutsuka T, Shimada S, Shiomori K, Hayashi N, Yagi Y, Yamane T, Ogawa M. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res 2003; 9:678-85. [More details]

  28. Shimada S, Yagi Y, Kuramoto M, Aoki N, Ogawa M. Second-line chemotherapy with combined irinotecan and low-dose cisplatin for patients with metastatic gastric carcinoma resistant to 5-fluorouracil. Oncol Rep 2003; 10:687-91. [More details]

Keywords Pancreatectomy; Pancreatic Neoplasms; Pancreaticoduodenectomy

Correspondence Masahiko Hirota: mhirota@kaiju.medic.kumamoto-u.ac.jp